Sidley advised Pivotal bioVenture Partners China (Pivotal), a leading venture capital fund in the field of life sciences, and Frazier Healthcare Partners (Frazier), a leading provider of growth and venture capital to healthcare companies, in the formation of SanReno Therapeutics (SanReno), a joint venture with Chinook Therapeutics, Inc. (Nasdaq: KDNY) (Chinook), a biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases, and the equity investment in SanReno. Continue reading

See all Member News